“…studies 39
Meta‐analysis: yes
Adults
Range: 500–20,000
| Community surveys using probability sampling | Diagnostic criteria, standardized instruments or clinician diagnosis |
Pooled one‐year and lifetime prevalence of:
Total anxiety disorders: 10.6% (7.5, 14.3), 16.6% (12.7, 21.1)
PD: 1.0% (0.6, 1.5), 1.2% (0.7, 1.9)
Agoraphobia: 1.6% (1.0, 2.3), 3.1% (2.1, 4.4)
SAD: 4.5% (3.0, 6.4), 2.5% (1.4, 4.0)
SP: 3.0% (1.0, 5.8) and 4.9% (3.4, 6.8)
OCD: 0.5% (0.3, 0.9), 1.3% (0.9, 1.8)
GAD: 2.6% (1.4, 4.2), 6.2% (4.0, 9.2)
Anxiety higher in women
SAD rates decline with age
Switzerland, US: 23–28.7; Korea: 9.2
|
Baxter 2013
Search: 2009
# incl. studies 87
Meta‐analysis: yes
|
44 countries across the globe
Median: 2419
| Community samples | Interview schedules, semi‐structured instruments, diagnostic instruments that mapped to DSM or ICD |
Global prevalence: 7.3% (4.8–10.9)
5.3% (3.5, 8.1) in African & 10.4% (7.0, 15.5) in Euro/Anglo cultures
Women 2× men; younger people more affected
Adults 55 + 20% less anxiety than 35–55
20–50% lower risk in cultures compared to Euro/Anglo
|
Mirza 2004
Search: March 2002
# incl. studies: 20
Meta‐analysis: no
|
Adults ages 18–65 years from community and clinical settings
Range: 113–2620
|
Population‐based, community, primary care samples; patients presenting to traditional or faith healers; psychiatric outpatients or inpatients
Clinical and community settings in Pakistan
| Psychiatric diagnoses, diagnoses made by trained workers using validated instruments |
Anxiety prevalence: 1.76–25%
Middle‐aged more affected
|
Vehling 2012
Search: not rep.
# incl. |
…”